The table below shows Cabaletta Bio, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$42.56M
-$30.80M
-$23.99M
-$12.61M
-$12.81M
-$8.67M
Capital expenditure
$0.00
$785.00K
$812.00K
$380.00K
$147.00K
$97.00K
Investing cash flow
$50.96M
-$785.00K
-$812.00K
$24.62M
-$49.91M
$2.35M
Dividends paid
-
-
-
-
CABA operating cash flow (10-K history)
Cabaletta Bio, Inc. reported operating cash flow of -$131.08M for fiscal year 2025. That is down 48.6% from -$88.22M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$4.66M (FY 2018) to -$131.08M. Figures come from the company's audited annual reports as filed with the SEC.